A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
Part of paid clinical trials in Auburn, Alabama.
- Sponsor
- Centessa Pharmaceuticals (UK) Limited
- Study ID
- NCT07096674
- Phase
- PHASE2
- Status
- Recruiting
Conditions
- Idiopathic Hypersomnia
- Narcolepsy Type 1
- Narcolepsy Type 2
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 65 Years
- Healthy Volunteers
- Not accepted
Interventions
Study Details
This study is a long-term extension (LTE) of the parent Study ORX750 0201, and will provide long-term open-label safety, tolerability, and efficacy of ORX750 in participants with narcolepsy type 1 (NT1), narcolepsy type 2 (NT2), and idiopathic hypersomnia (IH).
Key Dates
- Start date
- Aug 12, 2025
- Status verified
- Apr 2026
- Primary completion
- Apr 30, 2026
- Completion
- Apr 30, 2026
Study Design
- Enrollment
- 90 participants (estimated)
- Allocation
- NON_RANDOMIZED
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Narcolepsy Type 1Narcolepsy Type 1 (Open Label)
- Experimental: Narcolepsy Type 2Narcolepsy Type 2 (Open Label)
- Experimental: Idiopathic HypersomniaIdiopathic Hypersomnia (Open Label)
Primary Outcome Measure
Treatment Emergent Adverse Events (TEAEs) and Serious TEAEs [ Time Frame: Up to day 70 ]
Central Contacts
- Orexin Centessa Program Lead617-468-5770
Locations (19)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Auburn, alabama | Auburn | Alabama | 36832 | - |
| Santa Ana, California | Santa Ana | California | 92705 | - |
| Miami, Florida | Miami | Florida | 33176 | - |
| Orlando, Florida | Orlando | Florida | 32807 | - |
| Winter Park, FL | Winter Park | Florida | 32789 | - |
| Atlanta, Georgia | Atlanta | Georgia | 30328 | - |
| Stockbridge, GA | Atlanta | Georgia | 30281 | - |
| Sterling Heights, Michigan | Sterling Heights | Michigan | 48314 | - |
| Hendersen, Navada | Henderson | Nevada | 89052 | - |
| Henderson, Nevada | Henderson | Nevada | 89052 | - |
| Denver, North Carolina | Denver | North Carolina | 28037 | - |
| Huntersville, North Carolina | Huntersville | North Carolina | 28070 | - |
| Cincinnati, Ohio | Cincinnati | Ohio | 45245 | - |
| Dublin | Dublin | Ohio | 43017 | - |
| Abington, Pennsylvania | Abington | Pennsylvania | 19046 | - |
| Willow Grove, Pennsylvania | Willow Grove | Pennsylvania | 19090 | - |
| North Charleston, South Carolina | North Charleston | South Carolina | 29406-9196 | - |
| Austin, Texas | Austin | Texas | 30328 | - |
| El Paso, Texas | El Paso | Texas | 79912 | - |
Find similar trials in Auburn, AL
Related Studies
- A Study of TAK-861 for the Treatment of Selected Central Hypersomnia ConditionsPHASE2/PHASE3 · Recruiting · Takeda · Birmingham, Alabama
- Low Sodium Oxybate in Patients With Idiopathic HypersomniaPHASE4 · Recruiting · Mayo Clinic · Phoenix, Arizona
- Evaluating the Efficacy and Safety of PROSOMNIA Sleep Therapy™ in Patients With Sleep Deprivation and Chronic InsomniaPHASE1 · Not Yet Recruiting · Nyree Penn · Aventura, Florida
- A Study of ORX750 in Participants With Narcolepsy and Idiopathic HypersomniaPHASE2 · Recruiting · Centessa Pharmaceuticals (UK) Limited · Auburn, Alabama